CORRECTION: Jaguar Health Q4 EPS $0.42 Down From $0.57 YoY, Sales $2.30M Miss $2.61M Estimate
Portfolio Pulse from Benzinga Newsdesk
Jaguar Health (NASDAQ:JAGX) reported a decrease in Q4 EPS to $0.42 from $0.57 YoY and missed sales estimates with $2.30M against the expected $2.61M, marking a significant decline from the previous year.
April 01, 2024 | 1:32 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Jaguar Health reported a decrease in Q4 EPS to $0.42 from $0.57 YoY and missed sales estimates, reporting $2.30M against the expected $2.61M.
The reported decrease in EPS and missed sales estimates indicate a negative performance compared to the previous year, which is likely to negatively impact investor sentiment and potentially lead to a short-term decrease in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100